Argos Therapeutics to host conference call with principal investigator Dr. Robert Figlin on Monday June 8, 2015 at 4:30pm EDT Argos Therapeutics Inc. (Nasdaq: ARGS) ("Argos"), an immuno-oncology ...
IDMC recommends continuation of PM1183 Phase III trial in platinum-resistant ovarian cancer patients
PharmaMar (MSE:PHM) announced today that the Independent Data Monitoring Committee (IDMC) has notified the Company of its recommendation that the Phase III (CORAIL) trial currently under way with ...
Shares of clinical-stage biopharmaceutical Cara Therapeutics, Inc. CARA surged after the company announced that its phase III trial on lead candidate Korsuva (difelikefalin) can continue as planned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback